BE475216A - - Google Patents
Info
- Publication number
- BE475216A BE475216A BE475216DA BE475216A BE 475216 A BE475216 A BE 475216A BE 475216D A BE475216D A BE 475216DA BE 475216 A BE475216 A BE 475216A
- Authority
- BE
- Belgium
- Prior art keywords
- product
- soluble
- free
- alcohol
- protein
- Prior art date
Links
- 239000000047 product Substances 0.000 claims description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 40
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 36
- 239000000463 material Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 30
- 239000011780 sodium chloride Substances 0.000 claims description 30
- 241001465754 Metazoa Species 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 28
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 24
- 102000004877 Insulin Human genes 0.000 claims description 18
- 108090001061 Insulin Proteins 0.000 claims description 18
- 229940125396 insulin Drugs 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 208000002193 Pain Diseases 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 206010022562 Intermittent claudication Diseases 0.000 claims description 12
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims description 12
- 229960004373 acetylcholine Drugs 0.000 claims description 12
- 230000036772 blood pressure Effects 0.000 claims description 12
- 229960001340 histamine Drugs 0.000 claims description 12
- 208000021156 intermittent vascular claudication Diseases 0.000 claims description 12
- 210000000496 pancreas Anatomy 0.000 claims description 12
- 208000011726 slow pulse Diseases 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 230000002093 peripheral effect Effects 0.000 claims description 11
- 231100000331 toxic Toxicity 0.000 claims description 11
- 230000002588 toxic effect Effects 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 230000010339 dilation Effects 0.000 claims description 10
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 10
- 230000001052 transient effect Effects 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 230000002792 vascular Effects 0.000 claims description 9
- -1 hydrogen ions Chemical class 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 238000009795 derivation Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 210000001672 ovary Anatomy 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 210000005166 vasculature Anatomy 0.000 claims 2
- 230000017531 blood circulation Effects 0.000 claims 1
- 230000000916 dilatatory effect Effects 0.000 claims 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 13
- 238000005292 vacuum distillation Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000001476 alcoholic effect Effects 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 231100000701 toxic element Toxicity 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE475216A true BE475216A (enrdf_load_stackoverflow) |
Family
ID=123973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE475216D BE475216A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE475216A (enrdf_load_stackoverflow) |
-
0
- BE BE475216D patent/BE475216A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1052307A (fr) | Procede d'extraction et de traitement de glycoproteines, de mucopolysaccharides et de substances qui les accompagnent | |
| EP0349469B1 (fr) | Produit pharmaceutique doté d'activité de régénération de l'épiderme basé sur le principe actif du mimosa tenuiflora et procédé d'obtention correspondant | |
| EP0977550B1 (fr) | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique | |
| JP2004346045A (ja) | 海洋深層水を使用する酒造時に得られる酒粕抽出エキスを有効成分とする化粧料添加剤、入浴剤及び健康食品類 | |
| FR2512030A1 (fr) | Procede de preparation d'elastine soluble partiellement hydrolysee et son hydrolysat | |
| US7851441B2 (en) | Water-soluble elastin, process for producing same, and food and medicine containing same | |
| US2353016A (en) | Physiologically active substance | |
| BE475216A (enrdf_load_stackoverflow) | ||
| JPH03227985A (ja) | イチョウ葉からフラボノイドを高含有する抽出物の簡易な製造法 | |
| FR2509176A1 (fr) | Procede pour produire une preparation de tissus biologiques pour la therapie et la regeneration de cellules d'organismes vivants | |
| JP2000327549A (ja) | カムカムエキスを含む化粧料 | |
| RU2177033C1 (ru) | Способ производства водки | |
| FR2635114A1 (fr) | Procede de traitement de solutions proteiques contenant des pigments tels que groupements heminiques ou chlorophylles en vue de leur decoloration et produits obtenus | |
| US2897117A (en) | Insulin process | |
| FR2543438A1 (fr) | Composition pour la regeneration des cellules et des tissus de la peau et son procede d'obtention | |
| KR102301355B1 (ko) | 고 함량의 플라보노이드를 함유한 고기능 프로폴리스의 다량 추출 제조방법 | |
| CN118166057B (zh) | 一种生物活性肽的制备方法 | |
| US1978297A (en) | Testicular hormone and method of producing the same | |
| FR2630008A1 (fr) | Poudre de vers de terre sechee utile comme medicament et procede pour sa preparation | |
| JPH04149134A (ja) | アロエエキスの苦味成分を分離する方法 | |
| FR2693208A1 (fr) | Procédé d'obtention d'une composition enzymatique d'origine végétale ainsi que composition obtenue par la mise en Óoeuvre de ce procédé. | |
| CN104906164B (zh) | 黄刺果实多糖降血糖的用途 | |
| CN117959248A (zh) | 一种硒肽明目护眼液及其制备方法 | |
| RU2310465C1 (ru) | Способ получения жидкого экстракта конского каштана из семян конского каштана обыкновенного | |
| KR20210020342A (ko) | 발효 구인 추출물 천연화장품 |